The Award

This award recognises the pharma or large cap company that has demonstrated a superior excellence in strategy, process, focus and execution to create significant value for patients, shareholders and investors, employees and the broader community.

Judges paid particular attention to:

• Targeting unmet medical need/innovative approaches to pipeline development.
• Pipeline progress through drug discovery/pre-clinical/clinical stages.
• Progress of pipeline through to market approval.
• Key stages of strategic development/partnerships.
• Shareholder ROI/share price.

Company Description